A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A pediatric oncology group study
- 1 January 1989
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pediatric Oncology Group Utilization of Immunologic Markers in the Designation of Acute Lymphocytic Leukemia Subgroups: Influence on Treatment ResponseAnnals of the New York Academy of Sciences, 1984
- Pre-B cell leukemia responds poorly to treatment: a pediatric oncology group studyBlood, 1984
- Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1983
- Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphomaCancer, 1982
- Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia: a pediatric oncology group studyBlood, 1982
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observationJournal of Chronic Diseases, 1981
- Effective therapy for Burkitt's lymphoma: High-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapyCancer Chemotherapy and Pharmacology, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- FACTORS THAT INFLUENCE HAEMATOLOGICAL REMISSION DURATION IN ACUTE LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958